Trademarkia Logo

Canada

C$
QUVIVIQ
SEARCHED

on 15 Jan 2024

Last Applicant/ Owned by

Idorsia Pharmaceuticals Ltd

Hegenheimermattweg 91CH-4123 Allschwil

CH

Serial Number

2211172 filed on 6th Jul 2022

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

QUVIVIQ

Trademark usage description

pharmaceutical preparations intended for the prevention or treatment of cardiovascular diseases, hypertension, cerebral haemorrhages and sequela there Read More

Vienna Information


24 . 17 . 2

DotsPoints

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

Classification Information


Class [005]
Pharmaceutical preparations intended for the prevention or treatment of cardiovascular diseases, hypertension, cerebral haemorrhages and sequela thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergy diseases, autoimmune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, central nervous system diseases and disorders, dementia, insomnia, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage diseases, Fabry disease and Fabry disease symptoms and sequela, infectious diseases and cancer.


Classification kind code

11

Mark Details


Serial Number

2211172

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 256
on 11th Dec 2023
Notification of Possible Opposition Sent
Submitted for opposition 67
on 29th Sept 2023
Agent Name Changed
Submitted for opposition 210
on 9th Feb 2023
IR Correction
Submitted for opposition 257
on 9th Feb 2023
Designation Notification - Madrid Protocol
Submitted for opposition 48
on 6th Oct 2022
Agent Changed
Submitted for opposition 257
on 22nd Sept 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 21st Sept 2022
Created
Submitted for opposition 31
on 21st Sept 2022
Formalized
Submitted for opposition 30
on 6th Jul 2022
Filed
Submitted for opposition 228
on 6th Jul 2022
International Registration